25 XP   0   0   10

Zhejiang Cheng Yi Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Cheng Yi Pharmaceutical Co Ltd together

PenkeI guess you are interested in Zhejiang Cheng Yi Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Cheng Yi Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Cheng Yi Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Cheng Yi Pharmaceutical Co Ltd.

Quick analysis of Zhejiang Cheng Yi Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Cheng Yi Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.12
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.33
Expected worth in 1 year
¥4.46
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥1.97
Return On Investment
24.4%

For what price can you sell your share?

Current Price per Share
¥8.04
Expected price per share
¥5.78 - ¥8.45
How sure are you?
50%

1. Valuation of Zhejiang Cheng Yi Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.04

Intrinsic Value Per Share

¥-3.44 - ¥-1.71

Total Value Per Share

¥-0.10 - ¥1.62

2. Growth of Zhejiang Cheng Yi Pharmaceutical Co Ltd (5 min.)




Is Zhejiang Cheng Yi Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$150.5m$137.8m$12.7m8.4%

How much money is Zhejiang Cheng Yi Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$22.2m$23.5m-$1.2m-5.7%
Net Profit Margin24.7%24.6%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Cheng Yi Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Cheng Yi Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Zhejiang Cheng Yi Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Zhejiang Cheng Yi Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Zhejiang Cheng Yi Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Cheng Yi Pharmaceutical Co Ltd is ¥8.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Cheng Yi Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.33. Based on the TTM, the Book Value Change Per Share is ¥0.28 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.35 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.21 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.070.8%0.070.8%0.070.9%0.060.8%0.050.6%
Usd Book Value Change Per Share0.040.5%0.040.5%0.050.6%0.040.5%0.070.8%
Usd Dividend Per Share0.030.4%0.030.4%0.030.3%0.020.3%0.020.3%
Usd Total Gains Per Share0.070.8%0.070.8%0.070.9%0.060.8%0.091.1%
Usd Price Per Share1.93-1.93-2.24-2.63-2.47-
Price to Earnings Ratio28.34-28.34-31.10-44.83-52.12-
Price-to-Total Gains Ratio28.47-28.47-30.06-43.19-40.56-
Price to Book Ratio4.20-4.20-5.32-7.38-7.59-
Price-to-Total Gains Ratio28.47-28.47-30.06-43.19-40.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.10952
Number of shares901
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.02
Usd Book Value Change Per Share0.040.04
Usd Total Gains Per Share0.070.06
Gains per Quarter (901 shares)61.1056.76
Gains per Year (901 shares)244.39227.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
110514023478149217
2209280478155299444
3314420722233448671
4418560966311597898
552369912103897471125
662783914544668961352
7732979169854410451579
88361119194262211951806
99411259218670013442033
1010451399243077714932260

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Zhejiang Cheng Yi Pharmaceutical Co Ltd

About Zhejiang Cheng Yi Pharmaceutical Co Ltd

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, capsules, tablets, pharmaceutical intermediates in China. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Shanghai, China.

Fundamental data was last updated by Penke on 2024-04-18 14:15:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Cheng Yi Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Cheng Yi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 24.7% means that ¥0.25 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 24.7%. The company is making a huge profit. +2
  • The TTM is 24.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ24.7%TTM24.7%0.0%
TTM24.7%YOY24.6%+0.1%
TTM24.7%5Y21.6%+3.1%
5Y21.6%10Y21.3%+0.2%
1.1.2. Return on Assets

Shows how efficient Zhejiang Cheng Yi Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Cheng Yi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 9.4% Return on Assets means that Zhejiang Cheng Yi Pharmaceutical Co Ltd generated ¥0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 9.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.4%TTM9.4%0.0%
TTM9.4%YOY12.9%-3.5%
TTM9.4%5Y12.2%-2.8%
5Y12.2%10Y12.8%-0.7%
1.1.3. Return on Equity

Shows how efficient Zhejiang Cheng Yi Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Cheng Yi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 14.9% Return on Equity means Zhejiang Cheng Yi Pharmaceutical Co Ltd generated ¥0.15 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 14.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.9%TTM14.9%0.0%
TTM14.9%YOY17.3%-2.5%
TTM14.9%5Y16.6%-1.7%
5Y16.6%10Y17.0%-0.4%

1.2. Operating Efficiency of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Cheng Yi Pharmaceutical Co Ltd is operating .

  • Measures how much profit Zhejiang Cheng Yi Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Cheng Yi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY23.7%-23.7%
TTM-5Y17.0%-17.0%
5Y17.0%10Y19.4%-2.4%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Cheng Yi Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.11 means that the operating costs are ¥1.11 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 1.108. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.108. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.108TTM1.1080.000
TTM1.108YOY1.040+0.068
TTM1.1085Y1.071+0.037
5Y1.07110Y1.123-0.052

1.3. Liquidity of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Cheng Yi Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.69 means the company has ¥1.69 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 1.693. The company is able to pay all its short-term debts. +1
  • The TTM is 1.693. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.693TTM1.6930.000
TTM1.693YOY1.166+0.527
TTM1.6935Y1.634+0.060
5Y1.63410Y2.425-0.791
1.3.2. Quick Ratio

Measures if Zhejiang Cheng Yi Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Cheng Yi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.23 means the company can pay off ¥0.23 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 0.230. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.230. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.230TTM0.2300.000
TTM0.230YOY0.308-0.078
TTM0.2305Y0.308-0.078
5Y0.30810Y0.394-0.086

1.4. Solvency of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Cheng Yi Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Cheng Yi Pharmaceutical Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.37 means that Zhejiang Cheng Yi Pharmaceutical Co Ltd assets are financed with 36.5% credit (debt) and the remaining percentage (100% - 36.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 0.365. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.365. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.365TTM0.3650.000
TTM0.365YOY0.245+0.121
TTM0.3655Y0.256+0.110
5Y0.25610Y0.231+0.025
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Cheng Yi Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Cheng Yi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 57.7% means that company has ¥0.58 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The MRQ is 0.577. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.577. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.5770.000
TTM0.577YOY0.328+0.249
TTM0.5775Y0.358+0.219
5Y0.35810Y0.316+0.042

2. Market Valuation of Zhejiang Cheng Yi Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Cheng Yi Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Cheng Yi Pharmaceutical Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 28.34 means the investor is paying ¥28.34 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The EOD is 16.286. Based on the earnings, the company is fair priced.
  • The MRQ is 28.338. Based on the earnings, the company is overpriced. -1
  • The TTM is 28.338. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD16.286MRQ28.338-12.053
MRQ28.338TTM28.3380.000
TTM28.338YOY31.102-2.764
TTM28.3385Y44.826-16.488
5Y44.82610Y52.116-7.290
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The EOD is -30.277. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -52.683. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -52.683. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-30.277MRQ-52.683+22.407
MRQ-52.683TTM-52.6830.000
TTM-52.683YOY566.422-619.105
TTM-52.6835Y-462.647+409.963
5Y-462.64710Y-282.072-180.574
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Cheng Yi Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Cheng Yi Pharmaceutical Co Ltd:

  • The EOD is 2.412. Based on the equity, the company is underpriced. +1
  • The MRQ is 4.197. Based on the equity, the company is fair priced.
  • The TTM is 4.197. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.412MRQ4.197-1.785
MRQ4.197TTM4.1970.000
TTM4.197YOY5.318-1.121
TTM4.1975Y7.379-3.182
5Y7.37910Y7.592-0.212
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Cheng Yi Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2810.2810%0.348-19%0.300-6%0.476-41%
Book Value Per Share--3.3333.3330%3.052+9%2.699+23%2.312+44%
Current Ratio--1.6931.6930%1.166+45%1.634+4%2.425-30%
Debt To Asset Ratio--0.3650.3650%0.245+49%0.256+43%0.231+58%
Debt To Equity Ratio--0.5770.5770%0.328+76%0.358+61%0.316+82%
Dividend Per Share--0.2100.2100%0.192+9%0.156+34%0.148+42%
Eps--0.4940.4940%0.522-5%0.444+11%0.377+31%
Free Cash Flow Per Share---0.266-0.2660%0.029-1027%-0.112-58%-0.035-87%
Free Cash Flow To Equity Per Share---0.266-0.2660%-0.071-73%-0.143-46%0.018-1539%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.713--------
Intrinsic Value_10Y_min---3.438--------
Intrinsic Value_1Y_max---0.072--------
Intrinsic Value_1Y_min---0.172--------
Intrinsic Value_3Y_max---0.292--------
Intrinsic Value_3Y_min---0.670--------
Intrinsic Value_5Y_max---0.604--------
Intrinsic Value_5Y_min---1.331--------
Market Cap2631524160.000-74%4579020167.2324579020167.2320%5312176650.400-14%6237105919.366-27%5846589909.605-22%
Net Profit Margin--0.2470.2470%0.246+0%0.216+14%0.213+16%
Operating Margin----0%0.237-100%0.170-100%0.194-100%
Operating Ratio--1.1081.1080%1.040+7%1.071+3%1.123-1%
Pb Ratio2.412-74%4.1974.1970%5.318-21%7.379-43%7.592-45%
Pe Ratio16.286-74%28.33828.3380%31.102-9%44.826-37%52.116-46%
Price Per Share8.040-74%13.99013.9900%16.230-14%19.056-27%17.863-22%
Price To Free Cash Flow Ratio-30.277+43%-52.683-52.6830%566.422-109%-462.647+778%-282.072+435%
Price To Total Gains Ratio16.362-74%28.47128.4710%30.058-5%43.185-34%40.564-30%
Quick Ratio--0.2300.2300%0.308-25%0.308-25%0.394-42%
Return On Assets--0.0940.0940%0.129-27%0.122-23%0.128-27%
Return On Equity--0.1490.1490%0.173-14%0.166-10%0.170-13%
Total Gains Per Share--0.4910.4910%0.540-9%0.457+8%0.624-21%
Usd Book Value--150548600.823150548600.8230%137844994.978+9%121918078.324+23%104427728.550+44%
Usd Book Value Change Per Share--0.0390.0390%0.048-19%0.041-6%0.066-41%
Usd Book Value Per Share--0.4600.4600%0.421+9%0.372+23%0.319+44%
Usd Dividend Per Share--0.0290.0290%0.027+9%0.022+34%0.020+42%
Usd Eps--0.0680.0680%0.072-5%0.061+11%0.052+31%
Usd Free Cash Flow---11994403.388-11994403.3880%1294230.995-1027%-5062560.370-58%-1601250.118-87%
Usd Free Cash Flow Per Share---0.037-0.0370%0.004-1027%-0.015-58%-0.005-87%
Usd Free Cash Flow To Equity Per Share---0.037-0.0370%-0.010-73%-0.020-46%0.003-1539%
Usd Market Cap363150334.080-74%631904783.078631904783.0780%733080377.755-14%860720616.873-27%806829407.525-22%
Usd Price Per Share1.110-74%1.9311.9310%2.240-14%2.630-27%2.465-22%
Usd Profit--22298482.05722298482.0570%23570011.039-5%19987830.138+12%16985915.871+31%
Usd Revenue--90386252.09490386252.0940%95767138.295-6%92019997.624-2%78781697.761+15%
Usd Total Gains Per Share--0.0680.0680%0.075-9%0.063+8%0.086-21%
 EOD+3 -5MRQTTM+0 -0YOY+11 -245Y+15 -2010Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Cheng Yi Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.286
Price to Book Ratio (EOD)Between0-12.412
Net Profit Margin (MRQ)Greater than00.247
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.230
Current Ratio (MRQ)Greater than11.693
Debt to Asset Ratio (MRQ)Less than10.365
Debt to Equity Ratio (MRQ)Less than10.577
Return on Equity (MRQ)Greater than0.150.149
Return on Assets (MRQ)Greater than0.050.094
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Cheng Yi Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.773
Ma 20Greater thanMa 507.826
Ma 50Greater thanMa 1007.830
Ma 100Greater thanMa 2008.789
OpenGreater thanClose7.930
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,719,094
Total Liabilities628,162
Total Stockholder Equity1,087,885
 As reported
Total Liabilities 628,162
Total Stockholder Equity+ 1,087,885
Total Assets = 1,719,094

Assets

Total Assets1,719,094
Total Current Assets436,838
Long-term Assets1,282,256
Total Current Assets
Cash And Cash Equivalents 213,507
Net Receivables 59,302
Inventory 111,040
Other Current Assets 12,286
Total Current Assets  (as reported)436,838
Total Current Assets  (calculated)396,134
+/- 40,703
Long-term Assets
Property Plant Equipment 919,648
Intangible Assets 68,447
Long-term Assets Other 40,008
Long-term Assets  (as reported)1,282,256
Long-term Assets  (calculated)1,028,104
+/- 254,152

Liabilities & Shareholders' Equity

Total Current Liabilities257,988
Long-term Liabilities370,174
Total Stockholder Equity1,087,885
Total Current Liabilities
Short Long Term Debt 76,498
Accounts payable 54,789
Other Current Liabilities 1,283
Total Current Liabilities  (as reported)257,988
Total Current Liabilities  (calculated)132,570
+/- 125,418
Long-term Liabilities
Long term Debt 334,773
Capital Lease Obligations Min Short Term Debt906
Long-term Liabilities  (as reported)370,174
Long-term Liabilities  (calculated)335,679
+/- 34,495
Total Stockholder Equity
Retained Earnings 513,281
Total Stockholder Equity (as reported)1,087,885
Total Stockholder Equity (calculated)513,281
+/- 574,604
Other
Capital Stock233,789
Common Stock Shares Outstanding 327,304
Net Debt 197,764
Net Invested Capital 1,499,156
Net Working Capital 178,850
Property Plant and Equipment Gross 1,235,340



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
364,274
672,983
815,987
980,247
1,226,845
1,322,493
1,719,094
1,719,0941,322,4931,226,845980,247815,987672,983364,274
   > Total Current Assets 
180,996
467,226
343,822
317,182
282,307
287,797
436,838
436,838287,797282,307317,182343,822467,226180,996
       Cash And Cash Equivalents 
78,216
73,711
177,940
141,090
72,309
83,321
213,507
213,50783,32172,309141,090177,94073,71178,216
       Net Receivables 
44,825
47,518
53,384
65,415
66,344
75,936
59,302
59,30275,93666,34465,41553,38447,51844,825
       Inventory 
52,993
70,213
91,435
98,371
119,256
117,004
111,040
111,040117,004119,25698,37191,43570,21352,993
       Other Current Assets 
4,963
4,934
21,063
12,306
11,198
7,348
12,286
12,2867,34811,19812,30621,0634,9344,963
   > Long-term Assets 
183,277
205,757
472,166
663,065
925,774
1,034,696
1,282,256
1,282,2561,034,696925,774663,065472,166205,757183,277
       Property Plant Equipment 
126,230
139,067
317,838
580,450
592,997
668,664
919,648
919,648668,664592,997580,450317,838139,067126,230
       Goodwill 
0
0
10,246
10,246
5,246
2,415
0
02,4155,24610,24610,24600
       Intangible Assets 
22,084
28,670
34,940
32,501
70,872
70,192
68,447
68,44770,19270,87232,50134,94028,67022,084
       Other Assets 
9,440
11,906
82,986
15,766
51,583
85,228
0
085,22851,58315,76682,98611,9069,440
> Total Liabilities 
84,108
73,412
142,447
211,288
341,831
323,617
628,162
628,162323,617341,831211,288142,44773,41284,108
   > Total Current Liabilities 
81,749
70,883
137,570
202,197
227,375
246,867
257,988
257,988246,867227,375202,197137,57070,88381,749
       Short Long Term Debt 
12,000
0
0
10,012
40,043
86,363
76,498
76,49886,36340,04310,0120012,000
       Accounts payable 
25,660
20,606
34,933
84,208
61,110
57,495
54,789
54,78957,49561,11084,20834,93320,60625,660
       Other Current Liabilities 
22,844
19,547
29,955
20,480
34,230
85,743
1,283
1,28385,74334,23020,48029,95519,54722,844
   > Long-term Liabilities 
2,359
2,529
4,877
9,091
93,419
76,750
370,174
370,17476,75093,4199,0914,8772,5292,359
       Other Liabilities 
2,359
2,529
4,877
9,091
13,320
15,333
0
015,33313,3209,0914,8772,5292,359
       Deferred Long Term Liability 
0
575
1,556
1,240
1,286
2,244
0
02,2441,2861,2401,5565750
> Total Stockholder Equity
280,166
599,571
660,795
756,619
872,299
986,308
1,087,885
1,087,885986,308872,299756,619660,795599,571280,166
   Common Stock
63,900
85,200
119,280
119,280
166,992
233,789
0
0233,789166,992119,280119,28085,20063,900
   Retained Earnings 
93,396
127,702
188,830
284,438
401,869
514,219
513,281
513,281514,219401,869284,438188,830127,70293,396
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
0
0
96
313
213
220
0
02202133139600



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue638,239
Cost of Revenue-222,960
Gross Profit415,279415,279
 
Operating Income (+$)
Gross Profit415,279
Operating Expense-514,814
Operating Income123,425-99,535
 
Operating Expense (+$)
Research Development44,699
Selling General Administrative182,639
Selling And Marketing Expenses-
Operating Expense514,814227,337
 
Net Interest Income (+$)
Interest Income2,699
Interest Expense-14,370
Other Finance Cost-1,190
Net Interest Income-10,480
 
Pretax Income (+$)
Operating Income123,425
Net Interest Income-10,480
Other Non-Operating Income Expenses-
Income Before Tax (EBT)168,420123,425
EBIT - interestExpense = -14,370
172,998
187,368
Interest Expense14,370
Earnings Before Interest and Taxes (EBIT)-182,789
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax168,420
Tax Provision--3,780
Net Income From Continuing Ops172,200172,200
Net Income172,998
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-10,480
 

Technical Analysis of Zhejiang Cheng Yi Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The general trend of Zhejiang Cheng Yi Pharmaceutical Co Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Cheng Yi Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.26 < 8.39 < 8.45.

The bearish price targets are: 7.09 > 5.78.

Tweet this
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current macd is -0.06757658.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Cheng Yi Pharmaceutical Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Cheng Yi Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Cheng Yi Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current adx is 19.83.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Cheng Yi Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current sar is 7.09.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current rsi is 54.77. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Cheng Yi Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current cci is 49.75.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current cmo is 20.26.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current willr is -14.41441441.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Williams %R ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Cheng Yi Pharmaceutical Co Ltd.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current atr is 0.27393004.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current obv is 86,387,401.

Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Cheng Yi Pharmaceutical Co Ltd. The current mfi is 44.61.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Cheng Yi Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Cheng Yi Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Zhejiang Cheng Yi Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Cheng Yi Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.773
Ma 20Greater thanMa 507.826
Ma 50Greater thanMa 1007.830
Ma 100Greater thanMa 2008.789
OpenGreater thanClose7.930
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Cheng Yi Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Cheng Yi Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Cheng Yi Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Cheng Yi Pharmaceutical Co Ltd

I send you an email if I find something interesting about Zhejiang Cheng Yi Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Cheng Yi Pharmaceutical Co Ltd.

Receive notifications about Zhejiang Cheng Yi Pharmaceutical Co Ltd in your mailbox!